Golimumab Results Lead Off A Raft Of Updates For Alvotech
Firm Also Provides Updates On FDA Inspection And Adalimumab, Ustekinumab Expectations
Alvotech has provided a slew of updates on its biosimilars business, including clinical trial results for its Simponi rival as well as the latest on a key US FDA inspection of its manufacturing facility and fresh details around its launches of Humira and Stelara rivals in the US and around the world.
